Chondromyxoid fibroma

Chondromyxoid fibromas (CMFs) are extremely rare, benign cartilaginous neoplasms that account for <1% of all bone tumors 1.

As with all rare lesions, reported epidemiology varies:

  • age:
    • most commonly diagnosed before 30 years of age (~75%), mostly during second and third decades 1,12-15
    • full reported range from 3 to 70 years of age
  • gender:
    • conflicting data 2,12,18
    • some series show slight male predilection 15

Typically patients present with progressive pain, often long-standing and/or bony swelling and restricted range of movement in affected limb 3,12. The latter is most often the case in bones with little overlying soft tissues (e.g. short tubular bones of the hands and feet). 

The tumor comprises of a variable combination of chondroid, myxoid, and fibrous tissue components organised in a pseudolobulated architecture 20.

On gross examination, they are typically seen as solid glistening tan-gray intraosseous masses.

Occasional osteoclast-like giant multinucleated cells are encountered particularly at the periphery. Most cells are morphologically bland, and mitotic figures are rare or absent 13.  

Most chondromyxoid fibromas are located in the metaphyseal region of long bones (60%), and may extend to the epiphyseal line and even rarely abut the articular surface 3,12. They are almost never exclusively epiphyseal 3.  

The classical site is the upper one-third of the tibia, which accounts for 25% of all cases, with the small tubular bones of the foot, the distal femur and pelvis/sacrum being other relatively common locations 12

Rare cases involving the calvarium/skull base 25-27, and mandible 28, as well as the sternum 29 have been reported.

  • lobulated or oval eccentric lytic lesion
  • well defined sclerotic margin: ~85%
  • often expansile, with long axis parallel to long axis of long bone
  • no periosteal reaction (unless a complicating fracture present)
  • geographic bone destruction: almost 100%
  • presence of septations (pseudotrabeculation): ~60% 2
  • internal matrix calcification - uncommon by imaging (2-15%) 1,23
  • perilesional sclerosis 24

MR features are often not particularly specific. Signal characteristics include:

  • T1: low signal
  • T1 C+ (Gd)
    • majority (~70%) show peripheral nodular enhancement
    • ~30% diffuse contrast enhancement and this can be either homogeneous or heterogeneous 19
  • T2: intermediate to high signal 24
  • areas of low signal, both in peripheral rim and centrally, may correspond to perilesional sclerosis and minimal internal mineralisation, respectively

On bone scans, the scintigraphic "doughnut sign" has been described in this tumor type 11. However, this is non-specific and can be seen in many other bone lesions.

They are benign lesions and malignant degeneration is rare. There is a high rate of reported recurrence (up to 80%) with curettage alone, with lower rate (~20%) with bone grafting. As such if an en-bloc resection is possible this is advisable 14.

It is thought to have been initially described by H L Jaffe and L Lichtenstein in 1948 7.

General imaging differential considerations include:

Bone tumours

The differential diagnosis for bone tumors is dependent on the age of the patient, with a very different set of differentials for the pediatric patient.

Share article

Article information

rID: 10809
Synonyms or Alternate Spellings:
  • Chondromyxoid fibroma (CMF)
  • Chondromyxoid fibromas
  • CMF

Support Radiopaedia and see fewer ads

Cases and figures

  • Figure 1: CMF distribtuion
    Drag here to reorder.
  • Lateral
    Case 1
    Drag here to reorder.
  • Case 2: X ray
    Drag here to reorder.
  • Case 2: MRI
    Drag here to reorder.
  • Case 3
    Drag here to reorder.
  • Case 4
    Drag here to reorder.
  • Case 5
    Drag here to reorder.
  • Updating… Please wait.

     Unable to process the form. Check for errors and try again.

     Thank you for updating your details.